Please select the option that best describes you:
Topics:
Radiation Oncology • Genitourinary Cancers
What dose do you prescribe when treating the prostate in patients with low metastatic burden and what are your dose constraints?
The STAMPEDE trial recently published in Lancet used 55 Gy in 20 fractions but did not include dose constraints.
Answer from: Radiation Oncologist at Academic Institution
STAMPEDE also allowed 55 Gy in 20 fractions. I use the 60 Gy in 20 fraction regimen proven safe in CHHiP and PROFIT.
Comments
Radiation Oncologist at Mayo Clinic
60 Gy in 20 fractions.
60 Gy in 20 fractions.
Radiation Oncologist at Lake Huron Medical Center
60 Gy in 20 fractions, as well.
60 Gy in 20 fractions, as well.
Answer from: Radiation Oncologist at Academic Institution
We've been debating this issue at our institution, too. STAMPEDE also used a 6 Gy x6 delivered one fraction per week regimen. As these are patients likely to live a long time, even if not cured, then the goal in treating the prostate should be to achieve durable local control, while at the same...
Answer from: Radiation Oncologist at Community Practice
Converting to U.S.-style 5 fraction prostate SBRT, would anyone give 7.25 Gy per fraction x 5 fractions for 36.25 Gy, or use a different dose? Treating once weekly, twice weekly, or thrice weekly?
I recently queried several NHS consultants about t...
Here are (apparently) the STAMPEDE protocol dose o...
For the 55 Gy/20 fx regimen, the rectal constraint...
The PTV was defined by a 10mm margin (8mm posterio...